Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical FDA Record
- No warning letters matched by name
Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical has 64 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical" is on file. FDA has published 4 Form 483s for Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical.
- Latest recall
- D-0935-2020 · Class II · Jan 15, 2020
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 64 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical: FDA recall records per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 63 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 1 | 0 |
Reviewing Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical Form 483s
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0935-2020 | Class II | Alprostadil (prostaglandin E1)150 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL… | Jan 15, 2020 |
| D-0956-2020 | Class II | Human Chorionic Gonadotropin (hCG) Injection, HCG [10ML] 1000 IU/ML INJECTABLE, For IM, SC Use… | Jan 15, 2020 |
| D-0966-2020 | Class II | Methylcobalamin Injection, METHYLCOBALAMIN [CD] 10MG/100MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL… | Jan 15, 2020 |
| D-0982-2020 | Class II | Super MIC Injection, SUPER MIC* INJECTABLE, Vitamin Complex, For IM Use, 30 mL Multi-dose Vial, Rx… | Jan 15, 2020 |
| D-0946-2020 | Class II | Calcium Chloride Injection, For IM Use, Refrigerate, Shake Well, 30 mL Multi-dose Vial, Rx only… | Jan 15, 2020 |
| D-0947-2020 | Class II | Coenzyme Q10 Injection,COENZYME Q-10 20MG/ML OIL INJ SOLN, For IM Use, 10 mL Multi-dose Vial, Rx… | Jan 15, 2020 |
| D-0989-2020 | Class II | Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE Diacetate [10ML] CMC 10MG/ML INJ SUSP… | Jan 15, 2020 |
| D-0975-2020 | Class II | MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM… | Jan 15, 2020 |
| D-0934-2020 | Class II | Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30… | Jan 15, 2020 |
| D-0994-2020 | Class II | Zinc Chloride Injection, ZINC CHLORIDE 10MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial… | Jan 15, 2020 |
| D-0978-2020 | Class II | Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 20 MG/ML… | Jan 15, 2020 |
| D-0959-2020 | Class II | Arginine Hydrochloride Injection, L-ARGININE HCL 100MG/ML INJECTABLE, For IV, IM Use, 30 mL… | Jan 15, 2020 |
| D-0940-2020 | Class II | AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use… | Jan 15, 2020 |
| D-0985-2020 | Class II | Testosterone Cypionate/Progesterone Injection, TESTOSTERONE CYP/PROGESTERONE [2ML] 200MG/2.5MG/ML… | Jan 15, 2020 |
| D-0958-2020 | Class II | Hydroxyprogesterone Caproate Injection, HYDROXYPROGESTERONE CAPROATE [4ML] 250 MG/ML INJECTABLE, For… | Jan 15, 2020 |
| D-0976-2020 | Class II | Mitomycin-C (PF) Irrigation Solution, MITOMYCIN-C (PF) 0.5 MG/ML PF SYRINGE, For Intravesicular Use… | Jan 15, 2020 |
| D-0960-2020 | Class II | Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30… | Jan 15, 2020 |
| D-0936-2020 | Class II | Alprostadil (prostaglandin E1) 80 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL… | Jan 15, 2020 |
| D-0941-2020 | Class II | B-COMPLEX 110 INJECTABLE, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia… | Jan 15, 2020 |
| D-0943-2020 | Class II | BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone… | Jan 15, 2020 |
Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical and the FDA: common questions
Has Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical received an FDA warning letter?
No FDA warning letter addressed to the name "Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical received an FDA Form 483?
FDA has published 4 Form 483s for Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical in its reading room, the most recent dated Dec 19, 2019. FDA publishes some Form 483s, not all of them.
Has Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical had an FDA recall?
Yes. Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical has 64 FDA recalls on record. The most recent started Jan 15, 2020.
Need more than this page shows? Ask about Fusion IV Pharmaceuticals, Inc. Dba Axia Pharmaceutical in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.